Ortho Molecular Products - CM Core

CM Core - 90 CT

Ortho Molecular Products

$54.60
(No reviews yet) Write a Review
SKU:
OM-587090
Availability:
Ships Same Business Day
Minimum Purchase:
1 unit
Maximum Purchase:
3 units
Already Registered?
How to Gain Access to Store?

CM Core by Ortho Molecular Products – Cardiometabolic Support Supplement

CM Core by Ortho Molecular Products is a cardiometabolic support supplement formulated to promote healthy glucose metabolism, metabolic health, and overall cardiovascular support. This targeted blend features well-researched botanicals and antioxidants that work synergistically to support insulin function, healthy blood sugar balance, and cellular protection.

Key CM Core Benefits

  • Helps maintain healthy lipid levels
  • Provides antioxidant support for cellular health
  • Supports healthy inflammatory balance
  • Helps maintain healthy lipid levels
  • Promotes balanced cardiometabolic function

How CM Core Works

CM Core delivers a combination of clinically studied ingredients that support cardiometabolic wellness with a strong safety profile and minimal side effects. These ingredients work together to promote stable metabolic function without harsh stimulants or aggressive blood sugar–lowering effects:

  • Berberine HCl – Helps maintain healthy glucose uptake and insulin signaling while supporting microbial balance.
  • Alpha-Lipoic Acid (ALA) – A powerful antioxidant that supports mitochondrial function, healthy glucose utilization, and protection against oxidative stress.

Who Should Use CM Core

CM Core is ideal for individuals seeking a safe, natural way to support joint, bone, and skin health through improved metabolic and cellular function. It is also well-suited for those looking to maintain balanced blood sugar levels, enhance cardiovascular wellness, and support healthy aging.

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Or you may book a FREE product consultation with Holistic Health Partners. You may want to look at our other Cardiovascular Health products.

Recommendation: Ortho Molecular Products suggests taking 1 CoQ-10 300mg soft gel capsule per day or as recommended by your healthcare professional.

Serving Size: 1 soft gel capsule
Servings Per Container: 30 or 60

Amount Per Serving:
Berberine Hydrochloride Hydrate 1 g
Alpha Lipoic Acid (as R-Lipoic Acid) 200 mg
Calcium 80mg
 

Other Ingredients: D-Limonene Oil, Gelatin, Glycerin, Purified Water, Mixed Tocopherols, Red Radish Powder, Carob Extract Concentrate, Caramel Liquid, Medium Chain Triglycerides.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Click here to view Product Info Sheet

References:

  1. Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., & Smith, S. C. (2005). Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation, 112, 2735–2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  2. Jeong, H. W., Hsu, K. C., Lee, J. W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S., & Kim, J. B. (2009). Berberine suppresses proinflammatory responses through AMPK activation in macrophages. American Journal of Physiology-Endocrinology and Metabolism, 296, E955–E964. https://doi.org/10.1152/ajpendo.90778.2008
  3. Kemp, B., Stapleton, D., Campbell, D., Chen, Z. P., Murthy, S., Walter, M., Gupta, A., Adams, J., Katsis, F., & van Denderen, B. (2003). AMP-activated protein kinase, super metabolic regulator. Biochemical Society Transactions, 31, 162–168. https://doi.org/10.1042/bst0310162
  4. Towler, M. C., & Hardie, D. G. (2007). AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research, 100, 328–341. https://doi.org/10.1161/01.RES.0000256090.42690.68
  5. Lau, C. W., Yao, X. Q., Chen, Z. Y., Ko, W. H., & Huang, Y. (2001). Cardiovascular actions of berberine. Cardiovascular Drug Reviews, 19, 234–244. https://doi.org/10.1111/j.1527-3466.2001.tb00136.x
  6. Brusq, J. M., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y., & Issandou, M. (2006). Inhibition of lipid synthesis through activation of AMP kinase: An additional mechanism for the hypolipidemic effects of berberine. Journal of Lipid Research, 47, 1281–1288. https://doi.org/10.1194/jlr.M500497-JLR200
  7. Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., & Pan, H. (2004). Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine, 10, 1344–1351. https://doi.org/10.1038/nm1135
  8. Derosa, G., D’Angelo, A., Bonaventura, A., Bianchi, L., Romano, D., & Maffioli, P. (2013). Effects of berberine on lipid profile in subjects with low cardiovascular risk. Expert Opinion on Biological Therapy, 13, 475–482. https://doi.org/10.1517/14712598.2013.758709
  9. Zhang, H., Wei, J., Xue, R., Wu, J. D., Zhao, W., Wang, Z. Z., Wang, S. K., Zhou, Z. X., Song, D. Q., & Wang, Y. M. (2010). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism, 59, 285–292. https://doi.org/10.1016/j.metabol.2009.07.029
  10. Jäger, S., Handschin, C., Pierre, J. S., & Spiegelman, B. M. (2007). AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proceedings of the National Academy of Sciences, 104, 12017–12022. https://doi.org/10.1073/pnas.0705070104
  11. Zhou, L., Yang, Y., Wang, X., Liu, S., Shang, W., Yuan, G., Li, F., Tang, J., Chen, M., & Chen, J. (2007). Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism, 56, 405–412. https://doi.org/10.1016/j.metabol.2006.10.013
  12. Zhang, Q., Xiao, X., Feng, K., Wang, T., Li, W., Yuan, T., Sun, X., Sun, Q., Xiang, H., & Wang, H. (2011). Berberine moderates glucose and lipid metabolism through multipathway mechanism. Evidence-Based Complementary and Alternative Medicine, 2010, 1–10. https://doi.org/10.1155/2011/924589
  13. Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009). Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta (BBA)-General Subjects, 1790, 1149–1160. https://doi.org/10.1016/j.bbagen.2009.07.008
  14. Lee, W. J., Song, K. H., Koh, E. H., Won, J. C., Kim, H. S., Park, H. S., Kim, M. S., Kim, S. W., Lee, K. U., & Park, J. Y. (2005). α-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochemical and Biophysical Research Communications, 332, 885–891. https://doi.org/10.1016/j.bbrc.2005.05.064
  15. Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013). AMPK, insulin resistance, and the metabolic syndrome. The Journal of Clinical Investigation, 123, 2764–2772. https://doi.org/10.1172/JCI67227
  16. Jacob, S., Ruus, P., Hermann, R., Tritschler, H., Maerker, E., Renn, W., Augustin, H., Dietze, G., & Rett, K. (1999). Oral administration of RAC-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: A placebo-controlled pilot trial. Free Radical Biology and Medicine, 27, 309–314. https://doi.org/10.1016/S0891-5849(99)00089-1
  17. Packer, L., Witt, E. H., & Tritschler, H. J. (1995). Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine, 19, 227–250. https://doi.org/10.1016/0891-5849(95)00017-R